ARTICLES
May 17, 2013
Using infection prevention guidelines from the CDC can lead to a 32% decrease in overall bloodstream infections and a 54% decrease in vascular access-related bloodstream infections among dialysis patients, according to a new study.
Read More
May 16, 2013
Pentec Health Inc. has initiated a limited recall of some of its nutritional prescriptions for renal patients due to lack of sterility assurance associated with one of its laminar flow hoods used in compounding
Read More
May 14, 2013
Living close to a major road may impair kidney function, suggests research published online in the Journal of Epidemiology and Community Health
Read More
May 7, 2013
The U.S. Food and Drug Administration has approved a drug to treat nephropathic cystinosis
Read More
May 6, 2013
In a study that included more than 20,000 patients, there was a significant decrease in the United States in mortality rates over time among children and adolescents initiating end-stage renal disease treatment with dialysis between 1990 and 2010, according to a study in the May 8 issue of JAMA
Read More
May 2, 2013
NCS Research released the results of its Dialysis Anemia Trends survey of 175 dialysis professionals in the United States
Read More
May 2, 2013
Dialysis provider DaVita has received Ambulatory Health Care Accreditation from The Joint
Commission for its inpatient kidney care division
Read More
May 1, 2013
A drop in hemoglobin and ESA dose did not have a significant impact on self-reported quality of life using the KDQOL-36, according to a study by Lacson et al. and presented at the Annual Dialysis Conference last month
Read More
May 1, 2013
Cinacalcet, a drug commonly given to patients with end stage kidney disease to help keep phosphorus and parathyroid blood levels within a target range, has few patient level clinical benefits and several adverse effects, suggesting that it should no longer be routinely prescribed
Read More
April 30, 2013
The FDA has said it has determined that the drug Samsca (tolvaptan) should not be used for longer than 30 days and should not be used in patients with underlying liver disease because it can cause liver injury
Read More